Skip to main content
logo
Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2026, 11:07 AM EST

Regen BioPharma Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-0.72-1.27-0.671.162.44-6.77
Other Amortization
0.040.05-0.0300.070.05
Loss (Gain) From Sale of Investments
-----0.031.16
Stock-Based Compensation
0.540.130.20.250.050
Other Operating Activities
-0.410.6800.350-1.87
Change in Accounts Receivable
-0.11-0.11-0.090.25-0.04-0.11
Change in Accounts Payable
0.020-00-0.06-0.02
Change in Unearned Revenue
-0.13-0.13-0.14-0.11-0.131.84
Change in Other Net Operating Assets
0.280.27-0.02-2.07-2.914.59
Operating Cash Flow
-0.48-0.38-0.75-0.17-0.61-1.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Investment in Securities
----0.030.5
Investing Cash Flow
----0.030.5

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
-0.150.080.2401.36
Long-Term Debt Issued
-0.19----
Total Debt Issued
0.180.340.080.2401.36
Long-Term Debt Repaid
---0.01--0.09-
Total Debt Repaid
-0.05--0.01--0.09-
Net Debt Issued (Repaid)
0.130.340.070.24-0.091.36
Issuance of Common Stock
0.30.060.56---
Other Financing Activities
0.050.05----
Financing Cash Flow
0.480.450.630.24-0.091.36

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Miscellaneous Cash Flow Adjustments
-----0-
Net Cash Flow
-00.07-0.120.07-0.680.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Levered Free Cash Flow
-0.440.55-0.41-2.56-4.045.79
Unlevered Free Cash Flow
-0.350.63-0.31-2.52-3.985.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
----0.03-
Change in Working Capital
0.060.04-0.25-1.93-3.146.3